Companies / Maplight Therapeutics Inc / Activity
Activity — Maplight Therapeutics Inc
38 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 5, 2026 | Hanson Kristopher Executive | Grant | Voting Common Stock | $0 | +8K +4.20% | 191,582 0.42% of shares | low |
| Feb 5, 2026 | Setia Vishwas Executive | Grant | Voting Common Stock | $0 | +8K +1.99% | 395,549 0.87% of shares | low |
| Feb 5, 2026 | Kreitzer Anatol Executive | Grant | Voting Common Stock | $0 | +6K +2.37% | 259,928 0.57% of shares | low |
| Feb 5, 2026 | Foff Erin Pennock Executive | Grant | Voting Common Stock | $0 | +13K +3.42% | 403,835 0.89% of shares | low |
| Feb 5, 2026 | Lillie James Woodruff Executive | Grant | Voting Common Stock | $0 | +8K +2.66% | 298,862 0.66% of shares | low |
| Feb 5, 2026 | Gillis Jonathan Executive | Grant | Voting Common Stock | $0 | +6K +2.42% | 254,523 0.56% of shares | low |
| Feb 5, 2026 | Kroeger Christopher A. CEO | Grant | Voting Common Stock | $0 | +23K +1.42% | 1,649,751 3.64% of shares | low |
| Feb 3, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $18 | -1 -0.00% | 358,233 0.79% of shares | low |
| Feb 11, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $4.3K | -241 -0.07% | 351,370 0.77% of shares | low |
| Feb 23, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $9.1K | -476 -0.15% | 325,795 0.72% of shares | low |
| Jan 28, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $12.6K | -664 -0.17% | 393,147 0.87% of shares | low |
| Feb 24, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $13.4K | -736 -0.23% | 325,059 0.72% of shares | low |
| Feb 20, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $39.6K | -2K -0.65% | 337,059 0.74% of shares | low |
| Feb 19, 2026 | Pavlov George Director | Buy | Voting Common Stock | $77.7K | +4K +41.49% | 15,080 0.03% of shares | medium |
| Jan 28, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $109.1K | -6K -1.47% | 393,811 0.87% of shares | medium |
| Jan 30, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $119.7K | -7K -1.78% | 365,273 0.81% of shares | medium |
| Feb 10, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $120.0K | -7K -1.85% | 351,611 0.78% of shares | medium |
| Feb 2, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $126.8K | -7K -1.93% | 358,234 0.79% of shares | medium |
| Feb 20, 2026 | Pavlov George Director | Buy | Voting Common Stock | $177.2K | +10K +65.78% | 25,000 0.06% of shares | medium |
| Feb 18, 2026 | Pavlov George Director | Buy | Voting Common Stock | $186.3K | +11K | 10,658 0.02% of shares | medium |
| Feb 23, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $198.4K | -11K -3.20% | 326,271 0.72% of shares | medium |
| Feb 13, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $220.6K | -12K -3.45% | 339,254 0.75% of shares | medium |
| Feb 10, 2026 | Garnett Timothy John Director | Buy | Voting Common Stock | $252.7K | +14K | 14,124 0.03% of shares | medium |
| Jan 29, 2026 | Malenka Robert C. Director | Sell | Voting Common Stock | $394.4K | -21K -5.41% | 371,885 0.82% of shares | medium |
| Jan 27, 2026 | Gillis Jonathan Executive | Other | Voting Common Stock | $396.5K | -22K -8.15% | 248,503 0.55% of shares | low |
| Jan 27, 2026 | Hanson Kristopher Executive | Other | Voting Common Stock | $467.6K | -26K -12.39% | 183,852 0.41% of shares | low |
| Jan 27, 2026 | Setia Vishwas Executive | Other | Voting Common Stock | $600.2K | -33K -7.93% | 387,819 0.86% of shares | low |
| Jan 27, 2026 | Kreitzer Anatol Executive | Other | Voting Common Stock | $756.9K | -42K -14.22% | 253,908 0.56% of shares | low |
| Jan 27, 2026 | Foff Erin Pennock Executive | Other | Voting Common Stock | $802.2K | -45K -10.25% | 390,475 0.86% of shares | low |
| Jan 27, 2026 | Lillie James Woodruff Executive | Other | Voting Common Stock | $810.1K | -45K -13.40% | 291,132 0.64% of shares | low |
| Jan 27, 2026 | Kroeger Christopher A. CEO | Other | Voting Common Stock | $3.67M | -204K -11.15% | 1,626,606 3.59% of shares | low |
| Feb 5, 2026 | Hanson Kristopher Executive | Grant | Employee Stock Option (right to buy) | — | +31K | 31,395 0.07% of shares | low |
| Feb 5, 2026 | Setia Vishwas Executive | Grant | Employee Stock Option (right to buy) | — | +31K | 31,395 0.07% of shares | low |
| Feb 5, 2026 | Kreitzer Anatol Executive | Grant | Employee Stock Option (right to buy) | — | +24K | 24,455 0.05% of shares | low |
| Feb 5, 2026 | Foff Erin Pennock Executive | Grant | Employee Stock Option (right to buy) | — | +54K | 54,240 0.12% of shares | low |
| Feb 5, 2026 | Lillie James Woodruff Executive | Grant | Employee Stock Option (right to buy) | — | +31K | 31,395 0.07% of shares | low |
| Feb 5, 2026 | Gillis Jonathan Executive | Grant | Employee Stock Option (right to buy) | — | +24K | 24,455 0.05% of shares | low |
| Feb 5, 2026 | Kroeger Christopher A. CEO | Grant | Employee Stock Option (right to buy) | — | +94K | 93,955 0.21% of shares | low |